<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyTrialSummaryOutput xmlns:ns2="local" id="33109"><Title>Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder</Title><Indications><Indication>Hypoactive sexual desire disorder</Indication></Indications><Phase>Phase 3 Clinical</Phase><Drugs><Drug>flibanserin</Drug></Drugs><RecruitmentStatus>Completed</RecruitmentStatus><Sponsor>Sprout Pharmaceuticals</Sponsor></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyTrialSummaryOutput>